• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量研究胰蛋白酶和弹性蛋白酶对 SARS-CoV 体外感染的影响。

Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections.

机构信息

Department of Physics and Astronomy, Texas Christian University, Fort Worth, TX, United States.

Department of Physics and Astronomy, Texas Christian University, Fort Worth, TX, United States.

出版信息

Virus Res. 2021 Jul 2;299:198423. doi: 10.1016/j.virusres.2021.198423. Epub 2021 Apr 13.

DOI:10.1016/j.virusres.2021.198423
PMID:33845063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8043718/
Abstract

The SARS coronavirus (SARS-CoV) has the potential to cause serious disease that can spread rapidly around the world. Much of our understanding of SARS-CoV pathogenesis comes from in vitro experiments. Unfortunately, in vitro experiments cannot replicate all the complexity of the in vivo infection. For example, proteases in the respiratory tract cleave the SARS-CoV surface protein to facilitate viral entry, but these proteases are not present in vitro. Unfortunately, proteases might also have an effect on other parts of the replication cycle. Here, we use mathematical modeling to estimate parameters characterizing viral replication for SARS-CoV in the presence of trypsin or elastase, and in the absence of either. In addition to increasing the infection rate, the addition of trypsin and elastase causes lengthening of the eclipse phase duration and the infectious cell lifespan.

摘要

严重急性呼吸综合征冠状病毒(SARS-CoV)有可能引起严重疾病,并在全球迅速传播。我们对 SARS-CoV 发病机制的了解主要来自体外实验。不幸的是,体外实验无法复制体内感染的所有复杂性。例如,呼吸道中的蛋白酶可裂解 SARS-CoV 表面蛋白以促进病毒进入,但这些蛋白酶在体外不存在。不幸的是,蛋白酶也可能对复制周期的其他部分产生影响。在这里,我们使用数学建模来估计在存在胰蛋白酶或弹性蛋白酶以及不存在这两种蛋白酶的情况下 SARS-CoV 复制的特征参数。除了提高感染率外,胰蛋白酶和弹性蛋白酶的添加还会导致潜伏期和感染细胞寿命延长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db13/8043718/4221e2139562/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db13/8043718/26035a11e492/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db13/8043718/42f5bd594980/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db13/8043718/4221e2139562/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db13/8043718/26035a11e492/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db13/8043718/42f5bd594980/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db13/8043718/4221e2139562/gr3_lrg.jpg

相似文献

1
Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections.定量研究胰蛋白酶和弹性蛋白酶对 SARS-CoV 体外感染的影响。
Virus Res. 2021 Jul 2;299:198423. doi: 10.1016/j.virusres.2021.198423. Epub 2021 Apr 13.
2
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.蛋白酶介导的严重急性呼吸综合征冠状病毒感染增强作用。
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7. doi: 10.1073/pnas.0503203102. Epub 2005 Aug 22.
3
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.iota-卡拉胶中和 SARS-CoV-2 并抑制其体外复制。
PLoS One. 2021 Feb 17;16(2):e0237480. doi: 10.1371/journal.pone.0237480. eCollection 2021.
4
Structure-based phylogeny identifies avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice.基于结构的系统发育分析鉴定阿伏拉司他是一种 TMPRSS2 抑制剂,可预防小鼠感染 SARS-CoV-2。
J Clin Invest. 2021 May 17;131(10). doi: 10.1172/JCI147973.
5
Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells.铁抑素 II 可有效抑制 Vero 细胞中的 SARS-CoV-2 复制。
Viruses. 2022 Feb 3;14(2):317. doi: 10.3390/v14020317.
6
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity.强力霉素抑制假型病毒转导并不意味着能抑制 SARS-CoV-2 感染性。
Viruses. 2021 Sep 1;13(9):1745. doi: 10.3390/v13091745.
7
extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease .黄芩提取物和黄芩素抑制 SARS-CoV-2 及其 3CL 样蛋白酶的复制。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):497-503. doi: 10.1080/14756366.2021.1873977.
8
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).TMPRSS2 和 RNA 依赖性 RNA 聚合酶是治疗由 SARS-CoV-2 变异株(B.1.1.7 和 B.1.351)引起的 COVID-19 的有效治疗靶点。
Microbiol Spectr. 2021 Sep 3;9(1):e0047221. doi: 10.1128/Spectrum.00472-21. Epub 2021 Aug 11.
9
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.联合抑制宿主进入因子 PIKfyve 激酶和 TMPRSS2 蛋白酶对 SARS-CoV-2 感染的协同阻断。
J Virol. 2021 Oct 13;95(21):e0097521. doi: 10.1128/JVI.00975-21. Epub 2021 Aug 18.
10
The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.干扰素刺激的细胞外体 hACE2 通过竞争性阻断病毒进入来有效抑制 SARS-CoV-2 复制。
Signal Transduct Target Ther. 2021 May 12;6(1):189. doi: 10.1038/s41392-021-00604-5.

引用本文的文献

1
Host Cell Proteases Involved in Human Respiratory Viral Infections and Their Inhibitors: A Review.宿主细胞蛋白酶在人类呼吸道病毒感染中的作用及其抑制剂:综述。
Viruses. 2024 Jun 19;16(6):984. doi: 10.3390/v16060984.

本文引用的文献

1
Energy Requirements for Loss of Viral Infectivity.病毒感染力丧失所需的能量
Food Environ Virol. 2020 Dec;12(4):281-294. doi: 10.1007/s12560-020-09439-9. Epub 2020 Aug 5.
2
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
3
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
4
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.胰蛋白酶处理解锁了人畜共患蝙蝠冠状病毒感染的屏障。
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.01774-19.
5
Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.出版商更正:稳定的冠状病毒刺突蛋白对受体识别或蛋白水解诱导的构象变化具有抗性。
Sci Rep. 2018 Dec 10;8(1):17823. doi: 10.1038/s41598-018-36918-8.
6
A quantitative assessment of dynamical differences of RSV infections in vitro and in vivo.定量评估 RSV 感染在体外和体内的动力学差异。
Virology. 2018 Oct;523:129-139. doi: 10.1016/j.virol.2018.07.027. Epub 2018 Aug 23.
7
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.SARS 冠状病毒刺突糖蛋白与其宿主细胞受体 ACE2 复合物的冷冻电镜结构。
PLoS Pathog. 2018 Aug 13;14(8):e1007236. doi: 10.1371/journal.ppat.1007236. eCollection 2018 Aug.
8
A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time.呼吸道合胞病毒(RSV)与流感病毒体外动力学参数的比较揭示了感染时间的差异。
PLoS One. 2018 Feb 8;13(2):e0192645. doi: 10.1371/journal.pone.0192645. eCollection 2018.
9
Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.蝙蝠中丰富的与SARS相关冠状病毒基因库的发现为SARS冠状病毒的起源提供了新见解。
PLoS Pathog. 2017 Nov 30;13(11):e1006698. doi: 10.1371/journal.ppat.1006698. eCollection 2017 Nov.
10
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.TMPRSS2:抗流感病毒和冠状病毒感染治疗的潜在靶标。
Biochimie. 2017 Nov;142:1-10. doi: 10.1016/j.biochi.2017.07.016. Epub 2017 Aug 1.